Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)
Jul 31
Chinese (SSE) Life Sciences Industry Analysis
UpdatedAug 15, 2024
DataAggregated Company Financials
Companies24
- 7D-6.6%
- 3M-14.7%
- 1Y-41.7%
- YTD-37.5%
Over the last 7 days, the Life Sciences industry has dropped 6.6%, driven by a pullback from WuXi AppTec of 5.6%. Overall the industry is down 42% in 12 months. As for the next few years, earnings are expected to grow by 27% per annum.
Industry Valuation and Performance
Has the Chinese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 15 Aug 2024 | CN¥282.3b | CN¥87.6b | CN¥12.6b | 26.5x | 22.5x | 3.2x |
| Sat, 13 Jul 2024 | CN¥279.1b | CN¥88.3b | CN¥13.4b | 24.6x | 20.8x | 3.2x |
| Mon, 10 Jun 2024 | CN¥303.0b | CN¥88.3b | CN¥13.4b | 26.8x | 22.6x | 3.4x |
| Wed, 08 May 2024 | CN¥339.5b | CN¥88.3b | CN¥13.3b | 31.6x | 25.5x | 3.8x |
| Fri, 05 Apr 2024 | CN¥337.9b | CN¥90.3b | CN¥15.0b | 33.6x | 22.5x | 3.7x |
| Sun, 03 Mar 2024 | CN¥364.9b | CN¥90.5b | CN¥15.5b | 31.8x | 23.5x | 4x |
| Tue, 30 Jan 2024 | CN¥377.9b | CN¥91.1b | CN¥16.1b | 33.9x | 23.5x | 4.1x |
| Thu, 28 Dec 2023 | CN¥460.1b | CN¥91.1b | CN¥16.1b | 36.8x | 28.6x | 5.1x |
| Sat, 25 Nov 2023 | CN¥535.8b | CN¥91.1b | CN¥16.1b | 39.8x | 33.3x | 5.9x |
| Mon, 23 Oct 2023 | CN¥511.8b | CN¥92.2b | CN¥18.4b | 33.4x | 27.8x | 5.5x |
| Wed, 20 Sep 2023 | CN¥492.1b | CN¥92.0b | CN¥18.3b | 32.7x | 26.8x | 5.4x |
| Fri, 18 Aug 2023 | CN¥496.8b | CN¥91.6b | CN¥18.6b | 34.5x | 26.8x | 5.4x |
| Sun, 16 Jul 2023 | CN¥470.9b | CN¥91.3b | CN¥18.5b | 34.9x | 25.5x | 5.2x |
| Tue, 13 Jun 2023 | CN¥482.6b | CN¥91.3b | CN¥18.5b | 36.7x | 26.1x | 5.3x |
| Thu, 11 May 2023 | CN¥499.4b | CN¥91.5b | CN¥18.5b | 39.2x | 26.9x | 5.5x |
| Sat, 08 Apr 2023 | CN¥590.2b | CN¥90.8b | CN¥19.0b | 54.9x | 31.1x | 6.5x |
| Mon, 06 Mar 2023 | CN¥613.3b | CN¥85.5b | CN¥20.0b | 52x | 30.7x | 7.2x |
| Wed, 01 Feb 2023 | CN¥673.4b | CN¥86.6b | CN¥20.8b | 56.3x | 32.4x | 7.8x |
| Fri, 30 Dec 2022 | CN¥605.2b | CN¥86.6b | CN¥20.8b | 50.3x | 29.1x | 7x |
| Sun, 27 Nov 2022 | CN¥600.8b | CN¥86.6b | CN¥20.8b | 51.1x | 28.9x | 6.9x |
| Tue, 25 Oct 2022 | CN¥559.2b | CN¥78.3b | CN¥18.6b | 47.8x | 30.1x | 7.1x |
| Thu, 22 Sep 2022 | CN¥535.9b | CN¥77.8b | CN¥17.0b | 48.7x | 31.5x | 6.9x |
| Sat, 20 Aug 2022 | CN¥620.3b | CN¥73.4b | CN¥17.1b | 62.3x | 36.2x | 8.5x |
| Mon, 18 Jul 2022 | CN¥711.1b | CN¥69.0b | CN¥15.2b | 70.8x | 46.9x | 10.3x |
| Wed, 15 Jun 2022 | CN¥615.4b | CN¥69.0b | CN¥15.2b | 60.2x | 40.5x | 8.9x |
| Fri, 13 May 2022 | CN¥605.6b | CN¥68.5b | CN¥15.1b | 57.9x | 40x | 8.8x |
| Sun, 10 Apr 2022 | CN¥631.8b | CN¥62.7b | CN¥15.0b | 61.3x | 42.1x | 10.1x |
| Tue, 08 Mar 2022 | CN¥601.8b | CN¥60.9b | CN¥14.0b | 62.3x | 42.9x | 9.9x |
| Thu, 03 Feb 2022 | CN¥627.4b | CN¥57.5b | CN¥12.3b | 67.6x | 51x | 10.9x |
| Sat, 01 Jan 2022 | CN¥740.6b | CN¥57.5b | CN¥12.3b | 90.4x | 60.2x | 12.9x |
| Mon, 29 Nov 2021 | CN¥875.9b | CN¥56.9b | CN¥12.1b | 97.9x | 72.1x | 15.4x |
| Wed, 27 Oct 2021 | CN¥882.6b | CN¥54.0b | CN¥11.7b | 104.9x | 75.2x | 16.4x |
| Fri, 24 Sep 2021 | CN¥992.6b | CN¥55.1b | CN¥12.7b | 105.1x | 77.9x | 18x |
| Sun, 22 Aug 2021 | CN¥847.0b | CN¥55.1b | CN¥12.7b | 92.4x | 66.5x | 15.4x |
Price to Earnings Ratio
66.5x
Current Industry PE
- Investors are pessimistic on the Chinese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.5x which is lower than its 3-year average PE of 36.5x.
- The 3-year average PS ratio of 7.7x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -1.48% | |
| Healthcare | -1.78% | |
| Life Sciences | -6.55% | |
| Clinical Research and Equipment | -6.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300463 Maccura BiotechnologyLtd | CN¥12.08 | 0.5% +CN¥36.4m | -19.2% | PE21.6x |
